Genomic Health Inc (GHDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 47,116 | 46,317 | 43,439 | 41,229 | 39,583 |
| Cost of Goods | 8,708 | 8,853 | 8,107 | 8,966 | 8,543 |
| Gross Profit | 38,408 | 37,464 | 35,332 | 32,263 | 31,040 |
| Operating Expenses | 37,789 | 34,930 | 34,356 | 35,102 | 31,897 |
| Operating Income | 1,327 | 3,387 | 1,083 | -1,873 | -314 |
| Interest Expense | 0 | -13 | 21 | 21 | -45 |
| Other Income | 40 | 55 | 54 | 108 | 34 |
| Pre-tax Income | 1,367 | 3,455 | 1,116 | -1,786 | -235 |
| Income Tax | -318 | -215 | 251 | 146 | 107 |
| Net Income Continuous | 1,685 | 3,670 | 865 | -1,932 | -342 |
| Net Income | $1,685 | $3,670 | $865 | $-1,932 | $-342 |
| EPS Basic Total Ops | 0.06 | 0.13 | 0.03 | -0.07 | -0.01 |
| EPS Basic Continuous Ops | 0.06 | 0.13 | 0.03 | -0.07 | -0.01 |
| EPS Diluted Total Ops | 0.06 | 0.12 | 0.03 | -0.07 | -0.01 |
| EPS Diluted Continuous Ops | 0.06 | 0.12 | 0.03 | -0.07 | -0.01 |
| EBITDA(a) | $3,196 | $5,237 | $2,862 | $-191 | $1,409 |